The bill aims to give the Drug Enforcement Administration (DEA) additional tools to hold drug distributors, manufacturers and pharmacies accountable for identifying, reporting and stopping suspicious orders of controlled substances.
The bill aims to give the Drug Enforcement Administration (DEA) additional tools to hold drug distributors, manufacturers and pharmacies accountable for identifying, reporting and stopping suspicious orders of controlled substances.